Substance Abuse Nicotine Addiction Opioid Addiction Alcoholism Substance Use Tobacco Addiction Public Awareness Tobacco Use Community Support Alcohol Consumption Harm Reduction Community Impact Drug Policy Public Perception Opioid Crisis Alcohol Abuse Nicotine Products Gambling Smoking Recovery Drug Addiction Mental Health Awareness Social Impact Community Health Opioid Epidemic Smoking Cessation Food Addiction Chemsex Pharmaceutical Industry Opioid Overdoses Rehabilitation Impact on Family Alcohol Dependence Substance Use Disorders Recovery Support Personal Struggles Youth Protection Drug Use Human Rights Alcohol Use Nicotine Dependence Drug Overdose Crisis Management Prescription Drugs Treatment Access Comorbidity Drug Trends Patient Care Impact on Families Opioid Use Gambling Problems Nikotinsucht Overdose Prevention Mental Health Smoking-Related Diseases Fentanyl Crisis Gender Differences Cocaine Addiction Patient Trust Community Outreach Treatment Programs Overdose Deaths Support Systems Pediatric Exposures Public Health Opioid Overdose Suicide Prevention Opioid Dependence
The change shifts enforcement toward youth‑appealing product features, potentially expanding market access for well‑resourced firms.
